TargetMol

SB-334867 free base

Product Code:
 
TAR-T6140
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6140-1mg1mg£96.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6140-2mg2mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6140-1mL1 mL * 10 mM (in DMSO)£125.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6140-5mg5mg£125.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6140-10mg10mg£155.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6140-25mg25mg£248.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6140-50mg50mg£381.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6140-100mg100mg£533.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
SB-334867 is a selective orexin-1 (OX1) receptor antagonist.
CAS:
792173-99-0
Formula:
C17H13N5O2
Molecular Weight:
319.324
Pathway:
GPCR/G Protein; Neuroscience
Purity:
0.9975
SMILES:
Cc1nc2ccc(NC(=O)Nc3ccnc4cccnc34)cc2o1
Target:
OX Receptor

References

Smart D, et al. Br J Pharmacol. 2001, 132(6), 1179-1182. Rasmussen K, et al. Neuropsychopharmacology. 2007, 32(4), 786-792. Ranjbar-Slamloo Y, et al. Peptides. 2012, 35(1), 56-59. Haynes AC, et al. Regul Pept. 2000, 96(1-2), 45-51.